In hepatocellular carcinoma, HHLA2 is primarily expressed in the peritumor region, co-localizes with CD68+ macrophages and is associated with an immunosuppressive microenvironment, contributing to poor survival outcomes (Xu et al. 2021b, Wang et al. 2022). Here, HHLA2 is linked to hepatocellular carcinoma.